<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Liu X</submitter><pubmed_abstract>This work explored the mechanism of the effect of breast-cancer susceptibility gene 1 (&lt;i>BRCA1&lt;/i>) on the metabolic characteristics of breast cancer cells, including the Warburg effect and its specific signaling. We transfected MCF-7 cells with a &lt;i>BRCA1&lt;/i>-encoding LXSN plasmid or PKM2 siRNA and examined cancer cell metabolism using annexin V staining, inhibitory concentration determination, Western blotting, glucose uptake and lactic acid content measurements, and Transwell assays to assess glycolytic activity, cell apoptosis, and migration, and sensitivity to anti-cancer treatment. The &lt;i>BRCA1&lt;/i>-expressing MCF-7 cells demonstrated low PKM2 expression and decreased glycolytic activity (downregulated hexokinase 2 (HK2) expression, upregulated isocitrate dehydrogenase 1 (IDH1) expre</pubmed_abstract><journal>PeerJ</journal><pagination>e14052</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9526413</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect &lt;i>via&lt;/i> the PI3K/AKT signaling pathway.</pubmed_title><pmcid>PMC9526413</pmcid><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Zeng L</pubmed_authors><pubmed_authors>Lv Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect &lt;i>via&lt;/i> the PI3K/AKT signaling pathway.</name><description>This work explored the mechanism of the effect of breast-cancer susceptibility gene 1 (&lt;i>BRCA1&lt;/i>) on the metabolic characteristics of breast cancer cells, including the Warburg effect and its specific signaling. We transfected MCF-7 cells with a &lt;i>BRCA1&lt;/i>-encoding LXSN plasmid or PKM2 siRNA and examined cancer cell metabolism using annexin V staining, inhibitory concentration determination, Western blotting, glucose uptake and lactic acid content measurements, and Transwell assays to assess glycolytic activity, cell apoptosis, and migration, and sensitivity to anti-cancer treatment. The &lt;i>BRCA1&lt;/i>-expressing MCF-7 cells demonstrated low PKM2 expression and decreased glycolytic activity (downregulated hexokinase 2 (HK2) expression, upregulated isocitrate dehydrogenase 1 (IDH1) expre</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T11:31:16.482Z</modification><creation>2025-04-19T11:31:16.482Z</creation></dates><accession>S-EPMC9526413</accession><cross_references><pubmed>36193432</pubmed><doi>10.7717/peerj.14052</doi></cross_references></HashMap>